Results 111 to 120 of about 57,515 (223)
Nuclear ErbB-2: A Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?
Membrane overexpression of ErbB-2 (MErbB-2), a member of the ErbB family of receptor tyrosine kinases, occurs in 15– 20% of breast cancers (BC) and constitutes a therapeutic target in this BC subtype (ErbB-2-positive).
Elizalde, Patricia Virginia +4 more
core +1 more source
Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma
CONTEXT: p53, c-erbB-2 and epidermal growth factor receptor (EGFR) are cancer-related proteins that are usually expressed in head and neck squamous cell carcinoma (SCC). Their prognostic value remains controversial.
Orlando Parise Junior +3 more
doaj +1 more source
76 ÖZET Tümör oluşumunun en mükemmel modeli kolorektal kanser gelişimidir. Kolon kanser oluşumunda pek çok genetik ve epigenerik değişiklikler tespit edilmiştir. Ancak kolorektal kan serler halen tüm dünyada mortaliteye neden olan 4. kanserdir.
FATMA AYERDEN EBİNÇ
core
A recombinant murine retrovirus vector containing the v-erbB gene of avian erythroblastosis virus was constructed to investigate v-erbB as a transforming gene for mammalian cells.
J. H. Pierce +5 more
core +1 more source
目的: 研究 c -erbB-2, c-erbB-4 原癌基因过度表达与乳腺癌发生及其病理参数的相关关系。方法: 对 122 例乳腺疾病石蜡切块,其 中 80 例乳腺癌, 16 例乳腺纤维腺瘤, 9 例乳腺纤维囊性病, 17 例乳腺癌转移淋巴结均采用免疫组化( LSAB 法)结合计算机图象分析研究原癌 基因产物 c-erbB-2, c-erbB-4的表达情况。结果: c-erbB-2 在乳腺癌中存在过度表达, P
doaj
Aim: To analyze vascular endothelial growth factor (VEGF), c-erbB-2 and c-erbB-3 expression and to evaluate their relation to clinicopathologic parameters and pathogenesis of colorectal carcinoma.
Ebinc, FA +5 more
core
PURPOSE: To evaluate the prognostic significance and correlation with staging and degree of cell differentiation of the tumoral expression of the proteins c-erbB-2 and E-cadherin, in patients with colorectal adenocarcinoma.
Jesus Eliane C. +5 more
doaj
应用单克隆抗体C-erbB-2肿瘤蛋白及免疫组化(LSAB)法,对84例乳腺浸润性导管癌作C-erbB-2癌基因蛋白产物表达(简称C-erbB-2表达)检测并与随诊资料进行比较分析,结果(1)C-erbB-2在本组病例的表达率为55.9%(47/84)。(2)C-erbB-2表达与肿瘤的TNM分期、复发/远必转移、5a生存率无相关性(P>0.05)、而仅与腋淋巴结转移状况和2a死亡率有关(P<0.005及P<0.05)。(3)有/无淋巴结转移病例的C-erbB-2表达与患者的预后均无关(P>0.75 ...
doaj
Melanoma of the Scalp Harboring a Novel AGFG1::ERBB4 Fusion: A Case Report With Clinicopathologic and Genomic Characterization. [PDF]
Cao X +8 more
europepmc +1 more source

